The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
Open accessAbstract
A seeming paradox of sickle cell disease is that patients do not suffer from a high prevalence of systemic hypertension in spite of endothelial dysfunction, chronic inflammation and vasculopathy. However, some patients do develop systolic hypertension and increased pulse pressure, an increasingly recognized major cardiovascular risk factor in other populations. Hence, we hypothesized that pulse pressure, unlike other blood pressure parameters, is independently associated with markers of hemolytic anemia and cardiovascular risk in sickle cell disease. We analyzed the correlates of pulse pressure in patients (n = 661) enrolled in a multicenter international sickle cell trial. Markers of hemolysis were analyzed as independent variables and as a previously validated hemolytic index that includes multiple variables. We found that pulse pressure, not systolic, diastolic or mean arterial pressure, independently correlated with high reticulocyte count (beta = 2.37, p = 0.02) and high hemolytic index (beta = 1.53, p = 0.002) in patients with homozygous sickle cell disease in two multiple linear regression models which include the markers of hemolysis as independent variables or the hemolytic index, respectively. Pulse pressure was also independently associated with elevated serum creatinine (beta = 3.21, p = 0.02), and with proteinuria (beta = 2.52, p = 0.04). These results from the largest sickle cell disease cohort to date since the Cooperative Study of Sickle Cell Disease show that pulse pressure is independently associated with hemolysis, proteinuria and chronic kidney disease. We propose that high pulse pressure may be a risk factor for clinical complications of vascular dysfunction in sickle cell disease. Longitudinal and mechanistic studies should be conducted to confirm these hypotheses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, decreased autoregulation may allow the detrimental effects of elevated cerebral blood flow, pulse pressure (67), and velocity to be transmitted to the microcirculation and cause damage, as occurs in older individuals with atherosclerosis.”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694 · cited 1×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
ResultManagement of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599 · cited 1×
“These are recognized valuable screening tools of kidney dysfunction by the recently published sickle cell guidelines.[36] In summary, our results show that pulse pressure is closely linked to hemolysis in SCD and suggest that it may be an important predictor of cardiovascular risk.”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.[6, 8, 9] More recent studies have also shown that when an appropriate control po…”
BackgroundSelf-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Abnormal rheology of oxygenated blood in sickle cell anemia
Chien, S., Usami, S., & Bertles, J. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106273 · Cited by 356 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.”
BackgroundKaul, D. K., Fabry, M. E., & Nagel, R. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3356 · Cited by 335 · cited 1×
“Moreover, hemolysis is also linked to microvascular dysfunction in SCD, since the primary pathogenic process in this disease occurs at the level of the post-capillary venules and is characterized by cellular adhesion, vaso-occlusion, hemolysis and ischemiareperfusion injury.[30] Microvascular damage would lead to loss…”
BackgroundMinneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331 · cited 1×
“High plasma levels of free hemoglobin from hemolyzed RBC lead to nitric oxide depletion and reactive oxygen species formation which cause impaired vascular relaxation and increased arterial stiffness.[20] In addition, ischemia/reperfusion injury from acute episodes of vaso-occlusion and hemolysis also lead to the gene…”
BackgroundFalk, R. J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A., & Jennette, J. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204023261402 · Cited by 300 · cited 9×
“This hypothesis is supported by recent epidemiological evidence showing that systolic blood pressure rises as biomarkers of pulmonary hypertension and intravascular hemolysis increase, while diastolic blood pressure decreases as hemoglobin levels drop in SCD, leading to subgroups of patients developing systolic hypert…”
BackgroundInfluentialPegelow, M., Colangelo, M., Steinberg, M., Wright, P., Smith, M., Phillips, M., & Vichinsky, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00407-x · Cited by 274 · cited 3×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
ResultDivergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 273 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.[6, 8, 9] More recent studies have also shown that when an appropriate control po…”
BackgroundSelf-citationMachado, R. F., Barst, R. J., Yovetich, N. A., Hassell, K. L., Kato, G. J., Gordeuk, V. R., Gibbs, J. S. R., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Blood · doi:10.1182/blood-2010-09-306167 · Cited by 250 · cited 1×
“The study population and design have been described in detail elsewhere.[23, 24] Overall, we recruited 720 subjects age 12 and over at steady state from nine different study sites in the United States and one site in the United Kingdom, 671 (93.”
BackgroundSelf-citationNouraie, M., Lee, J. S., Zhang, Y., Kanias, T., Zhao, X., Xiong, Z., Oriss, T. B., Zeng, Q., Kato, G. J., Gibbs, J. S. R., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.068965 · Cited by 226
Self-citationBenetos, A., Thomas, F., Joly, L., Blacher, J., Pannier, B., Labat, C., Salvi, P., Smulyan, H., & Safar, M. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.061 · Cited by 221 · cited 1×
“The result of increased pulse pressure is greater vascular load on the heart, which can lead to myocardial hypertrophy and heart failure,[17] and end-organ damage in other vascular districts, including the kidney (reviewed in[18]) and the brain.”
BackgroundLarge and Small Artery Cross-Talk and Recent Morbidity-Mortality Trials in Hypertension
Laurent, S., Briet, M., & Boutouyrie, P. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133116 · Cited by 217
Belhassen, L., Pelle, G., Sediame, S., Bachir, D., Carville, C., Bucherer, C., Lacombe, C., Galacteros, F., & Adnot, S. (2001) · Blood · doi:10.1182/blood.v97.6.1584 · Cited by 202 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.[6, 8, 9] More recent studies have also shown that when an appropriate control po…”
BackgroundMorris, C. R., Suh, J. H., Hagar, W., Larkin, S., Bland, D. A., Steinberg, M. H., Vichinsky, E. P., Shigenaga, M., Ames, B., Kuypers, F. A., et al. (2008) · Blood · doi:10.1182/blood-2007-04-081703 · Cited by 191 · cited 1×
“[20] In addition, ischemia/reperfusion injury from acute episodes of vaso-occlusion and hemolysis also lead to the generation of pathologic reactive oxygen species responsible for endotheliopathy and endothelial inflammation.[21, 22] The hemodynamic consequences of high baseline hemolysis and anemia are high cardiac o…”
BackgroundPulse Pressure and Resistance Artery Structure in the Elderly
James, M. A., Watt, P. A. C., Potter, J. F., Thurston, H., & Swales, J. D. (1995) · Hypertension · doi:10.1161/01.hyp.26.2.301 · Cited by 164 · cited 1×
“Elevated pulse pressure would in turn damage small vessels and lead to microvascular rarefaction in a vicious cycle.[18, 31] It is, therefore, possible that hemolysis may mechanistically link both micro and microvascular dysfunction and that elevated pulse pressure may be a result of cross-talk between large and small…”
BackgroundGordeuk, V. R., Sachdev, V., Taylor, J. G., Gladwin, M. T., Kato, G. J., & Castro, O. L. (2007) · American Journal of Hematology · doi:10.1002/ajh.21016 · Cited by 149 · cited 1×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
ResultSelf-citationSachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032920 · Cited by 147
Self-citationReactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136 · cited 1×
“[20] In addition, ischemia/reperfusion injury from acute episodes of vaso-occlusion and hemolysis also lead to the generation of pathologic reactive oxygen species responsible for endotheliopathy and endothelial inflammation.[21, 22] The hemodynamic consequences of high baseline hemolysis and anemia are high cardiac o…”
BackgroundHypertension and Vascular Dynamics in Men and Women With Metabolic Syndrome
Safar, M. E., Balkau, B., Lange, C., Protogerou, A. D., Czernichow, S., Blacher, J., Levy, B. I., & Smulyan, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.088 · Cited by 127 · cited 4×
“[15] Under physiological conditions in young subjects, the backward pressure wave returns from the distal arterial compartment during diastole, cause pulse pressure to be higher in peripheral than in central arteries, a phenomenon known as pulse pressure amplification.[15] In conditions where pulse wave velocity and a…”
BackgroundInfluentialSaraf, S. L., Zhang, X., Kanias, T., Lash, J. P., Molokie, R. E., Oza, B., Lai, C., Rowe, J. H., Gowhari, M., Hassan, J., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12690 · Cited by 120 · cited 1×
“A larger proportion of HbSS patients had proteinuria, a marker of sickle cell nephropathy, recently shown to be predicted by hemolysis and hemoglobinuria,[26] and chronic kidney disease stage I or higher.”
BackgroundSelf-citationEffect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 109 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.”
BackgroundAlbuminuria and Renal Function in Homozygous Sickle Cell Disease: Observations From a Cohort Study
Thompson, J., Reid, M., Hambleton, I., & Serjeant, G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.701 · Cited by 99 · cited 1×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
ResultArterial Blood Pressure in Adults With Sickle Cell Disease
Johnson, C. S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340070071015 · Cited by 96 · cited 1×
“[1] This large study confirmed findings of prior smaller series showing lower baseline blood pressure values are characteristic of SCD patients.[2, 3] Multiple hypotheses have been formulated over the following years to explain the paradox of a population affected by severe endotheliopathy and vasculopathy and acceler…”
ResultRosano, C., Watson, N. L., Chang, Y., Newman, A. B., Aizenstein, H. J., Du, Y., Venkatraman, V. K., Harris, T. B., Barinas‐Mitchell, E., & Sutton-Tyrrell, K. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.198069 · Cited by 90 · cited 1×
“The result of increased pulse pressure is greater vascular load on the heart, which can lead to myocardial hypertrophy and heart failure,[17] and end-organ damage in other vascular districts, including the kidney (reviewed in[18]) and the brain.[19] Hemolysis in SCD causes endothelial dysfunction via multiple mechanis…”
BackgroundSelf-citationIs “Relative” Hypertension a Risk Factor for Vaso-occlusive Complications in Sickle Cell Disease?
Rodgers, G. P., Walker, E. C., & Podgor, M. J. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199303000-00004 · Cited by 67 · cited 1×
“[1] This large study confirmed findings of prior smaller series showing lower baseline blood pressure values are characteristic of SCD patients.[2, 3] Multiple hypotheses have been formulated over the following years to explain the paradox of a population affected by severe endotheliopathy and vasculopathy and acceler…”
ResultThe impact of body mass index on pulse pressure in obesity
Kwagyan, J., Tabe, C. E., Xu, S., Maqbool, A. R., Gordeuk, V. R., & Randall, O. S. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160220.71350.5f · Cited by 51 · cited 9×
“This hypothesis is supported by recent epidemiological evidence showing that systolic blood pressure rises as biomarkers of pulmonary hypertension and intravascular hemolysis increase, while diastolic blood pressure decreases as hemoglobin levels drop in SCD, leading to subgroups of patients developing systolic hypert…”
BackgroundInfluentialRole of Pulse Pressure on Cardiovascular Risk in Chronic Kidney Disease Patients
Fernández‐Fresnedo, G., Rodrigo, E., de Francisco, Á. L. M., de Castro, S. S., Castañeda, O., & Arias, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080921 · Cited by 43 · cited 1×
“[12] Elevated pulse pressure has recently emerged as an independent predictor of cardiovascular outcomes and prognostic factor for death in patients at high risk of cardiovascular morbidity and mortality such as aging patients and those affected by advanced chronic kidney disease.[13, 14] The main determinants of puls…”
BackgroundSasongko, T. H., Nagalla, S., & Ballas, S. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009191.pub3 · Cited by 37
Adolescent Blood Pressure in a Cohort Study of Sickle Cell Disease
Homi, J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410100063009 · Cited by 26 · cited 1×
“[5] Adjustment for the lower BMI of SCD patients as compared to that of control subjects has proved to be particularly important in evaluating blood pressure differences.[5, 10, 11] Another possibility is that systolic, diastolic and mean arterial pressure may not be the systemic pressure parameters most reflective of…”
BackgroundArterial Stiffness and Stroke in Sickle Cell Disease
Belizna, C. C., Loufrani, L., Ghali, A., Lahary, A., Primard, E., Louvel, J., Henrion, D., Levesque, H., & Ifrah, N. (2011) · Stroke · doi:10.1161/strokeaha.111.635383 · Cited by 26 · cited 9×
“This hypothesis is supported by recent epidemiological evidence showing that systolic blood pressure rises as biomarkers of pulmonary hypertension and intravascular hemolysis increase, while diastolic blood pressure decreases as hemoglobin levels drop in SCD, leading to subgroups of patients developing systolic hypert…”
BackgroundInfluentialDesai, P. C., Deal, A. M., Brittain, J. E., Jones, S., Hinderliter, A. L., & Ataga, K. I. (2012) · American Journal of Hematology · doi:10.1002/ajh.23278 · Cited by 18 · cited 5×
“[5] Adjustment for the lower BMI of SCD patients as compared to that of control subjects has proved to be particularly important in evaluating blood pressure differences.[5, 10, 11] Another possibility is that systolic, diastolic and mean arterial pressure may not be the systemic pressure parameters most reflective of…”
BackgroundResultInfluentialArterial blood pressure in adult Nigerian sickle cell anaemia patients.
Aderibigbe, A., Omotoso, A. B., Awobusuyi, J. O., & Akande, T. M. (1999) · PubMed · Cited by 16
Blood pressure and cardiovascular disease: what remains to be achieved?
Franklin, S. S. (2001) · PubMed · Cited by 16
Sasongko, T. H., Nagalla, S., & Ballas, S. K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009191.pub2 · Cited by 16 · cited 1×
“While angiotensinconverting enzyme inhibitors may reduce proteinuria in SCD patients,[34] there is no clear evidence to show which patients may benefit the most from these medications.”
Background[Arterial pressure and urinary excretion of albumin in adults with sickle cell disease].
Foucan, L., Salmi, L., Billy-Brissac, R., Bourhis, V., & Bangou, J. (1995) · PubMed · Cited by 3
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationWare, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationCardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Self-citationKidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC
Drawz, P. E., Ayyappan, S. R., Nouraie, M. S., Saraf, S. L., Gordeuk, V. R., Hostetter, T. H., Gladwin, M. T., & Little, J. A. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03940415 · Cited by 116
Self-citation
Metadata
- Authors
- Novelli, E. M., Hildesheim, M., Rosano, C., Vanderpool, R., Simon, M., Kato, G. J., & Gladwin, M. T.
- Affiliations
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Corresponding author
- Novelli, Enrico M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-05
- Volume
- 9
- Issue
- 12
- Pages
- e114309
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4257593
- OpenAlex
- W1995941333
- Cited by
- 38
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 4 · 2015: 1
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, public-domain)
- Funders
- Hemophilia Center of Western Pennsylvania
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- sickle cell disease, pulse pressure, hemolysis, reticulocyte count, hemolytic index, proteinuria, chronic kidney disease, hypertension, cardiovascular risk, endothelial dysfunction, serum creatinine
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Pressure, Child, Female, Hemolysis, Humans, Male, Middle Aged, Proteinuria, Biomarkers, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.